Searched for: +
(1 - 20 of 93)

Pages

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis
Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis
Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis
Salsalate activates brown adipose tissue in mice
Salsalate activates brown adipose tissue in mice
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Anacetrapib reduces (V)LDL-cholesterol by inhibition of CETP activity and reduction of plasma PCSK9
Anacetrapib reduces (V)LDL-cholesterol by inhibition of CETP activity and reduction of plasma PCSK9
Metformin lowers plasma triglycerides by promoting vldl-triglyceride clearance by brown adipose tissue in mice
Metformin lowers plasma triglycerides by promoting vldl-triglyceride clearance by brown adipose tissue in mice
Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B
Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B
RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice
RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice
Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: A prospective, case-controlled observational study
Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: A prospective, case-controlled observational study
P430RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice
P430RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
Sympathetic nervous system control of triglyceride metabolism
Sympathetic nervous system control of triglyceride metabolism: Novel concepts derived from recent studies
Inhibition of the central melanocortin system decreases brown adipose tissue activity
Inhibition of the central melanocortin system decreases brown adipose tissue activity
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake
Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake
Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice
Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice
CD36 is important for adipocyte recruitment and affects lipolysis
CD36 is important for adipocyte recruitment and affects lipolysis
Searched for: +
(1 - 20 of 93)

Pages